reference standard raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-12-20 and is reviewed periodically as new material appears.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water; stock solutions use organic solvent. |
| Storage | -20°C, desiccated, protected from light | Limits hydrolysis and photodegradation. |
| Analytical method | HPLC-UV/MS | Used for identity and purity assessment. |
| Synonyms | SR9009, Stenabolic | Naming varies by supplier. |
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
20 October 2023 Mid Bedfordshire by-election: Labour MP Alistair Strathern wins the constituency of Mid Bedfordshire, with the Conservatives' share of the vote falling by 28.7%, one of the largest swings of the post-war era. 2023 Tamworth by-election: Labour MP Sarah Edwards wins the constituency of Tamworth, with the Conservatives' share of the vote falling by 25.6%. Sunak meets Palestinian Authority leader Mahmoud Abbas in Egypt, where they jointly condemn Hamas's attacks on Israel. Sunak also "expressed his deep condolences" for civilian deaths in Gaza. Data from the Office for National Statistics shows UK government borrowing was at £14.3bn in September 2023, lower than the £18.3bn that had been forecast by economists. Moody's drops its negative credit rating for the UK, saying that "policy predictability has been restored" following the September 2022 mini-budget. 21 October A report prepared by the Royal College of Psychiatrists suggests more support is needed to prevent children under the age of five from going on to develop mental health problems in later life. A pro-Palestinian protest is held in London. Although the main event passes without incident, video subsequently emerges of a man chanting "jihad" at a separate rally, but the Metropolitan Police say no offence has been committed after reviewing the film. Following a discussion on the matter with the home secretary, Metropolitan Police chief Sir Mark Rowley says hate crime laws "probably need redrawing". 2023 Rugby World Cup: England are defeated by South Africa in the Rugby World Cup semi-final.
== Research == Much of the research conducted on demyelinating diseases is targeted towards discovering the mechanisms by which these disorders function in an attempt to develop therapies and treatments for individuals affected by these conditions. For example, proteomics has revealed several proteins which contribute to the pathophysiology of demyelinating diseases. For example, COX-2 has been implicated in oligodendrocyte death in animal models of demyelination. The presence of myelin debris has been correlated with damaging inflammation as well as poor regeneration, due to the presence of inhibitory myelin components. N-cadherin is expressed in regions of active remyelination and may play an important role in generating a local environment conducive to remyelination. N-cadherin agonists have been identified and observed to stimulate neurite growth and cell migration, key aspects of promoting axon growth and remyelination after injury or disease. Immunomodulatory drugs such as fingolimod have been shown to reduce immune-mediated damage to the CNS, preventing further damage in patients with MS. The drug targets the role of macrophages in disease progression. CNS-selective thyromimetics may become a viable strategy to protect myelin and promote remyelination in MS patients. It has been shown that intranasal administration of apotransferrin (aTf) can protect myelin and induce remyelination in mice. Finally, electrical stimulation which activates neural stem cells may provide a method by which regions of demyelination can be repaired.
=== Leader of the BC Conservatives (May–September 2026) === On May 30, 2026, Findlay was elected leader of the Conservative Party of British Columbia with 51% of the vote. She took over from interim leader Trevor Halford following the resignation of John Rustad in December 2025. During the leadership campaign, Findlay faced criticism within her own party for saying fellow leadership candidate Peter Milobar had a conflict of interest when it comes to reconciliation because his wife is Indigenous. In response, Milobar called Findlay's attacks "the worst side of politics possible,” suggesting her victory would “give a lot of British Columbians pause for thought of whether they would actually vote for a party like this.” He would later leave the party in August 2026. Findlay has also received criticism from former Conservative MLA Elenore Sturko, who called her "radical on the right wing," saying she’s been copied on several emails from B.C. Conservative members cancelling their memberships. Former BC United MLA Karin Kirkpatrick called Findlay's victory "very, very bad for the Conservative party." On June 29, she conducted a shadow cabinet reshuffle, appointing MLA Heather Maahs as leader of the Opposition. On July 3, 2026, former BC Conservative MLA Amelia Boultbee crossed the floor to join the governing BC NDP caucus, citing a shift toward "Trump-style populism" under new BC Conservative leader Findlay as the reason she would not be returning to its caucus.
Sources: en.wikipedia.org
== Interactions == Extracellular interaction with a tripartite receptor composed of gp130, WSX1, and CNTFR, as well as interaction with the formyl peptide receptor 2 (formylpeptide-like-1 receptor) have been published. Intracellular interaction with BAX, tBID, IGFBP3, and TRIM11 may also be required for the effects of humanin.
== See also == Ketoconazole, another antifungal agent used in shampoos Piroctone olamine, another antifungal agent used in shampoos Selenium disulfide, an active ingredient used in shampoos such as Selsun Blue
=== Inhibitors of NF-κB activity === Concerning known protein inhibitors of NF-κB activity, one of them is IFRD1, which represses the activity of NF-κB p65 by enhancing the HDAC-mediated deacetylation of the p65 subunit at lysine 310, by favoring the recruitment of HDAC3 to p65. In fact IFRD1 forms trimolecular complexes with p65 and HDAC3. The NAD+-dependent protein deacetylase and longevity factor SIRT1 inhibits NF-κB gene expression by deacetylating the RelA/p65 subunit of NF-κB at lysine 310.
Sources: en.wikipedia.org
The third and final season of the American psychological drama television series Euphoria, inspired by Ron Leshem's miniseries of the same name, premiered on HBO on April 12, 2026. Series creator Sam Levinson serves as showrunner for the season. The season centers on recovering addict young adult Rue Bennett navigating her faith while also being drawn into the illegal drug trade. Zendaya stars as Rue alongside an ensemble cast consisting of Hunter Schafer, Jacob Elordi, Sydney Sweeney, Alexa Demie, Maude Apatow, Eric Dane, Adewale Akinnuoye-Agbaje, Martha Kelly, Chloe Cherry, and Toby Wallace. In February 2022, Euphoria was renewed for a third season. Filming commenced in February 2025 and wrapped in November. The season consists of eight episodes and received mixed reviews from critics. At the 78th Primetime Emmy and Creative Arts Awards the season was nominated seven times with Zendaya receiving her third nomination for Outstanding Lead Actress in a Drama Series. On May 31, 2026, the same day that the final episode of the third season was released, HBO confirmed that the series had concluded after three seasons.
=== Nuclear Magnetic Resonance Spectroscopy === NMR spectroscopy plays a crucial role in characterizing cage formation and dynamics in solution. Solution-state NMR allows researchers to monitor reaction progress and confirm structural features through chemical shift analysis and coupling patterns. Two-dimensional NMR techniques help establish connectivity patterns and verify the successful formation of key structural features. This solution-phase characterization complements solid-state analysis by providing insight into the cage's behavior under practical application conditions.
Armaan Kohli, Indian actor Bisham Kohli, Indian film personality, better known as Vishal Anand Girish Kohli (born 1983), Indian author and screenwriter Gurdeep Kohli (born 1980), Indian actor Hardeep Singh Kohli (born 1969), British presenter Himansh Kohli (born 1989), Indian actor Jas Kohli, Indian author Kuku Kohli (born 1949), Indian director, writer, editor and screenwriter Kunal Kohli (born 1969), Indian film director, producer and writer Narendra Kohli (1940–2021), Indian Hindi-language author Neelu Kohli, Indian television actress Nishi (actress) (born 1935), Indian actor Purab Kohli (born 1979), Indian actor, model and former video jockey Rahul Kohli, English actor Rajkumar Kohli (1930–2023), Indian film director Raul Kohli, English standup comedian Rochak Kohli (born 1983), Indian music director, composer, singer, instrumentalist and lyricist Sanjeev Kohli (born 1971), British Indian comedian, writer and actor Seema Kohli, Indian artist Sunita Kohli, Indian interior designer Vikas Kohli, Indian musician and music producer
Following his death, Logan appears posthumously in two recordings - the first for the assisted living community Living+ and the second an archival recording of a dinner party with his employees and Connor, of which his children Kendall, Roman, and Shiv become emotional upon viewing.
Sources: en.wikipedia.org
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.
The solid is generally kept cold, dry, and protected from light. Solutions are often frozen in single-use aliquots to reduce repeated freeze-thaw cycles.
It indicates a material sold for laboratory study, not for human use. The label does not guarantee pharmaceutical purity, sterility, or regulatory approval.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.